SEMELCEF 200 mg tablets for dogs and cats
SEMELCEF 200 mg tablets for dogs and cats
Authorised
- Cefadroxil monohydrate
Product identification
Medicine name:
SEMELCEF 200 mg tablets for dogs and cats
Active substance:
- Cefadroxil monohydrate
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Cefadroxil monohydrate210.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01DB05
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Cyprus
Available in:
-
Cyprus
Package description:
- box containing 10 blisters of 10 tablets (100 tablets)
- box containing 1 blister of 10 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
- CY00741V
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0304/001
Concerned member states:
-
Austria
-
Belgium
-
Croatia
-
Cyprus
-
Czechia
-
Estonia
-
Greece
-
Hungary
-
Ireland
-
Poland
-
Portugal
-
Slovakia
-
Slovenia
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 25/12/2023
Greek (PDF)
Published on: 16/01/2026
Package Leaflet
English (PDF)
Download Published on: 25/12/2023
Labelling
English (PDF)
Download Published on: 25/12/2023
Combined File of all Documents
English (PDF)
Download Published on: 24/07/2025
eu-PUAR-esv0304001-dcp-semelcef-200-mg-tablets-for-dogs-and-cats-en.pdf
English (PDF)
Download Published on: 25/12/2023
